These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 9296552
1. Tardive dyskinesia: who is at risk? van Os J, Fahy T, Jones P, Harvey I, Toone B, Murray R. Acta Psychiatr Scand; 1997 Sep; 96(3):206-16. PubMed ID: 9296552 [Abstract] [Full Text] [Related]
2. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM. Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112 [Abstract] [Full Text] [Related]
3. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V. van Harten PN, Hoek HW, Matroos GE, van Os J. J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270 [Abstract] [Full Text] [Related]
5. Use of aripiprazole in tardive dyskinesia: an open label study of six cases. Rajarethinam R, Dziuba J, Manji S, Pizzuti A, Lachover L, Keshavan M. World J Biol Psychiatry; 2009 Dec; 10(4 Pt 2):416-9. PubMed ID: 19492247 [Abstract] [Full Text] [Related]
6. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis. Apud JA, Egan MF, Wyatt RJ. Schizophr Res; 2003 Sep 01; 63(1-2):151-60. PubMed ID: 12892869 [Abstract] [Full Text] [Related]
8. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group. van Os J, Walsh E, van Horn E, Tattan T, Bale R, Thompson SG. Acta Psychiatr Scand; 2000 Apr 01; 101(4):300-6. PubMed ID: 10782550 [Abstract] [Full Text] [Related]
10. Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course. Eberhard J, Lindström E, Levander S. Int Clin Psychopharmacol; 2006 Jan 01; 21(1):35-42. PubMed ID: 16317315 [Abstract] [Full Text] [Related]
12. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication. Glazer WM, Morgenstern H, Schooler N, Berkman CS, Moore DC. Br J Psychiatry; 1990 Oct 01; 157():585-92. PubMed ID: 1983390 [Abstract] [Full Text] [Related]
13. Treatment of tardive dyskinesia with donepezil: a pilot study. Caroff SN, Campbell EC, Havey J, Sullivan KA, Mann SC, Gallop R. J Clin Psychiatry; 2001 Oct 01; 62(10):772-5. PubMed ID: 11816865 [Abstract] [Full Text] [Related]
19. Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics. Rittmannsberger H. Psychiatr Danub; 2008 Dec 01; 20(4):461-5. PubMed ID: 19011586 [Abstract] [Full Text] [Related]
20. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Morgenstern H, Glazer WM. Arch Gen Psychiatry; 1993 Sep 01; 50(9):723-33. PubMed ID: 8102845 [Abstract] [Full Text] [Related] Page: [Next] [New Search]